Stock Events

Stock Events

Xcelerate 

$0.023900
5
+$0.00+1.7%Monday 15:48

Statistics

Day High
0.0255
Day Low
0.0255
52W High
0.028
52W Low
0.0061
Volume
10,000
Avg. Volume
78,615
Mkt Cap
10.38M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

Aug 27Expected
Q2 2011
Q3 2011
Q4 2011
Q2 2012
Q3 2012
Q1 2013
Q2 2013
-0
-0
0
0
Expected EPS
N/A
Actual EPS
-0.0002

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-1.22MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson is a competitor due to its involvement in the healthcare sector, offering a wide range of products and services that can overlap with Xcelerate's offerings.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a direct competitor in the pharmaceutical and biotech sectors, areas where Xcelerate aims to innovate and grow.
Merck
MRK
Mkt Cap368.89B
Merck operates in the pharmaceutical industry, directly competing with Xcelerate in the development and marketing of drugs and therapies.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes in the biopharmaceutical field, making it a competitor to Xcelerate in terms of drug development and healthcare solutions.
AMGEN
AMGN
Mkt Cap251.94B
Amgen, a biotech firm, competes with Xcelerate in the areas of biotechnological innovation and therapeutic solutions.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is involved in the discovery, development, and delivery of medicines, competing with Xcelerate in the pharmaceutical and healthcare market.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is a biopharmaceutical company that competes with Xcelerate in developing and commercializing innovative therapies.
Novartis
NVS
Mkt Cap303.67B
Novartis is a global healthcare company that competes with Xcelerate in the pharmaceuticals and healthcare services sectors.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with Xcelerate in the pharmaceutical and diagnostics business, particularly in the development of medicines and tools.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific competes with Xcelerate by providing scientific research services, equipment, and healthcare solutions that overlap with Xcelerate's market.

About

Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents, which it then applies to nascent medical technology ventures. The firm's offerings are subsequently deployed within regulated clinical settings for rigorous evaluation, validation, and real-world implementation. Beyond this, the company oversees a comprehensive, full-spectrum approach to medical technology creation and deployment. Established in 1996, the Mauldin, South Carolina-based entity was previously known as Union Dental Holdings, Inc. before rebranding as Xcelerate Inc.
Show More
CEO
Michael F. O'Shea
Employees
12
Country
United States
ISIN
US98401T1051

Listings

OTC Link
US
XCRT

0 Comments

Share your thoughts

FAQs

What is Xcelerate stock price today?▼
The current price of XCRT is $0.02 USD — it has increased by +1.7% in the past 24 hours. Watch Xcelerate stock price performance more closely on the chart.
What is Xcelerate stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Xcelerate stocks are traded under the ticker XCRT.
Is Xcelerate stock price growing?▼
XCRT stock has fallen by -0.73% compared to the previous week, the month change is a -2.85% fall, over the last year Xcelerate has showed a +104.27% increase.
What is Xcelerate market cap?▼
Today Xcelerate has the market capitalization of 10.38M
What were Xcelerate earnings last quarter?▼
XCRT earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xcelerate revenue for the last year?▼
Xcelerate revenue for the last year amounts to 0 USD.
What is Xcelerate net income for the last year?▼
XCRT net income for the last year is -1.22M USD.
How many employees does Xcelerate have?▼
As of November 3, 2026, the company has 12 employees.
In which sector is Xcelerate located?▼
Xcelerate operates in the Health & Wellness sector.
When did Xcelerate complete a stock split?▼
Xcelerate has not had any recent stock splits.
Where is Xcelerate headquartered?▼
Xcelerate is headquartered in Mauldin, United States.